null

SMILES: [H][C@]1(CC[C@@H](CC1)OC(=O)C#Cc1cc(OC)c(OC)c(OC)c1)N(C)[C@H]1CC[C@@H](CC1)OC(=O)C1c2ccccc2-c2ccccc12

InChI Key: InChIKey=URRSSYRSFVEQPP-SVBXLRLBSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50489303   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
ATP-dependent translocase ABCB1 (Homo sapiens (Human))	BDBM50489303 (CHEMBL2316441) Show SMILES [H][C@]1(CC[C@@H](CC1)OC(=O)C#Cc1cc(OC)c(OC)c(OC)c1)N(C)[C@H]1CC[C@@H](CC1)OC(=O)C1c2ccccc2-c2ccccc12 |r,wU:26.27,1.0,wD:4.7,29.34,(20.82,-1.29,;20.84,-2.83,;20.84,-4.37,;19.51,-5.13,;18.18,-4.37,;18.18,-2.83,;19.51,-2.05,;16.84,-5.14,;15.51,-4.37,;15.51,-2.83,;14.18,-5.15,;12.84,-5.93,;11.51,-6.7,;10.18,-5.93,;8.85,-6.71,;7.52,-5.95,;7.51,-4.41,;8.86,-8.25,;7.53,-9.03,;6.19,-8.27,;10.21,-9.02,;10.22,-10.56,;8.9,-11.34,;11.53,-8.23,;22.17,-2.06,;22.18,-.52,;23.51,-2.84,;24.83,-2.08,;26.17,-2.86,;26.16,-4.4,;24.82,-5.16,;23.49,-4.39,;27.49,-5.18,;28.83,-4.42,;28.84,-2.88,;30.15,-5.2,;31.57,-4.58,;32.05,-3.13,;33.55,-2.81,;34.58,-3.96,;34.09,-5.42,;32.59,-5.73,;31.82,-7.06,;32.28,-8.52,;31.25,-9.65,;29.74,-9.32,;29.28,-7.85,;30.32,-6.73,)| Show InChI InChI=1S/C39H43NO7/c1-40(26-14-18-28(19-15-26)46-36(41)22-13-25-23-34(43-2)38(45-4)35(24-25)44-3)27-16-20-29(21-17-27)47-39(42)37-32-11-7-5-9-30(32)31-10-6-8-12-33(31)37/h5-12,23-24,26-29,37H,14-21H2,1-4H3/t26-,27-,28+,29-	PDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	120	n/a	n/a	n/a	n/a	n/a	n/a
Universit£ di Firenze Curated by ChEMBL					Assay Description Inhibition of P-glycoprotein in human doxorubicin-resistant K562 cells assessed as half maximal increase of pirarubicin accumulation by spectrofluoro...				Bioorg Med Chem 21: 456-65 (2013) Article DOI: 10.1016/j.bmc.2012.11.019 BindingDB Entry DOI: 10.7270/Q2ST7SQM
					More data for this Ligand-Target Pair